The Senate confirmed Dr. Erica Schwartz as the new director of the Centers for Disease Control and Prevention on Wednesday. The vote followed weeks of debate over her public health record and policy positions.
Dr. Schwartz previously served as deputy surgeon general during the first Trump administration. Her confirmation marks a significant leadership change for the federal agency tasked with disease prevention and response.
Supporters of Dr. Schwartz pointed to her extensive federal experience and her public endorsement of childhood vaccines. They argued her background would bring stability to the agency during a period of heightened public scrutiny.
Critics, however, raised concerns about her past statements on pandemic measures and her alignment with certain political factions. Those worries did not prevent her confirmation, which passed with bipartisan support.
During her confirmation hearings, Dr. Schwartz emphasized her commitment to evidence-based science and transparent communication. She also pledged to rebuild trust in the agency following years of mixed public messaging.
Public health experts note that Dr. Schwartz’s next steps will be closely watched, particularly regarding vaccine rollout strategies and data sharing with state health departments. Her leadership comes as the agency faces new infectious disease threats and chronic health challenges.
Dr. Schwartz is expected to begin her term immediately and will oversee a budget of over $8 billion. Her first major priority, according to aides, will be updating the agency’s rapid response protocols for emerging outbreaks.
